Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
Clinical trial NCT00075465 · UNKNOWN
Trial details
- NCT number
- NCT00075465
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.